Skip to main content

RHUMBLINE ADVISERS

Position in SLN — Silence Therapeutics plc

CIK 1115418 BOSTON, MA

Position in SLN

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$151,688
+$78,251 QoQ
Shares Held
13,815
-0.9% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 72 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SLN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. SLN ranks #258 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SLN

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $151,688 13,815
2026-03-31 $73,437 13,935
2025-12-31 $79,033 12,999
2025-09-30 $30,439 5,865
2025-06-30 $35,936 6,196
2025-03-31 $5,287 1,875
2024-12-31 $5,786 841
2024-09-30 $13,707 754
2024-06-30 $8,911 469
2024-03-31 $324 15
2023-12-31 $86 5
2023-09-30 $49 5